Downloads: 113 | Views: 474
Review Papers | Pharmacology Science | India | Volume 9 Issue 6, June 2020 | Rating: 6.2 / 10
Hantavirus: Past and Future
Shravani Vishwas Girigosavi
Abstract: Hantaviruses have been known to exist for over 40 years, hantavirus is cause of the hemorrhagic fever and renal syndrome. Hantavirus was first recognized as an infectious disease in the early 1950s when a cluster of 3000 United Nation troops stationed in Korea was struck by a mysterious illness. Many genomes, proteins plays different roles in hantaviruses such as genomic RNAs also receptors that is C1q receptor (gC1qR) or G1 and G2 glycoproteins. Previous studies show that individuals suffering from hantavirus pulmonary syndrome disease. In recent years, there are no US FDA – approved vaccines against hantaviruses. China and South Korea, in both countries, the use of vaccines, combined have been researched ; DNA vaccines targeting the genome segment, subunit vaccines that use recombinant Gn, Gc and N protein of virus. Virus like particle vaccines that contain viral protein but lack genetic material. These, only DNA vaccines have entered into clinical trials. Our aim this review is to display Past and Future Hantavirus, and effect of Hantavirus Pulmonary Syndrome.
Keywords: Hantavirus, Rodent reservoirs, Hemorrhagic fever, Renal syndrome
Edition: Volume 9 Issue 6, June 2020,
Pages: 1647 - 1653